MINK THERAPEUTICS INC (INKT) Stock Analyst Ratings
NASDAQ:INKT - Nasdaq - US6036932019 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 84% to INKT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 21.42. This target is 5.47% above the current price.
INKT was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about INKT.
In the previous month the buy percentage consensus was at a similar level.
INKT was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-07-15 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-07-14 | William Blair | Downgrade | Outperform -> Market Perform |
| 2025-03-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-25 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-15 | Baird | Maintains | Outperform -> Outperform |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-04-19 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-22 | Evercore ISI Group | Maintains | Outperform |
| 2023-03-22 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-08-10 | HC Wainwright & Co. | Initiate | Buy |
| 2022-01-24 | B. Riley Securities | Maintains | Buy |
| 2021-11-09 | William Blair | Initiate | Outperform |
| 2021-11-09 | Evercore ISI Group | Initiate | Outperform |
| 2021-11-09 | Baird | Initiate | Outperform |